TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 160 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q2 2016. The put-call ratio across all filers is 0.17 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $4,299,000 | -4.8% | 30,007 | +2.7% | 1.50% | -5.8% |
| Q4 2015 | $4,514,000 | -71.2% | 29,205 | -73.4% | 1.60% | -71.0% |
| Q3 2015 | $15,673,000 | +7.3% | 109,687 | +7.9% | 5.51% | +26.0% |
| Q2 2015 | $14,611,000 | +34.6% | 101,681 | +32.1% | 4.38% | +23.9% |
| Q1 2015 | $10,853,000 | -7.9% | 76,957 | -3.3% | 3.53% | -24.1% |
| Q4 2014 | $11,790,000 | +20.8% | 79,557 | +25.4% | 4.65% | +28.0% |
| Q3 2014 | $9,758,000 | -25.3% | 63,420 | -31.9% | 3.63% | -42.1% |
| Q2 2014 | $13,061,000 | +25.9% | 93,133 | -0.3% | 6.27% | +37.9% |
| Q1 2014 | $10,371,000 | +26.1% | 93,433 | +12.4% | 4.54% | +20.5% |
| Q4 2013 | $8,222,000 | +25.3% | 83,132 | -3.7% | 3.77% | -3.3% |
| Q3 2013 | $6,560,000 | +116.1% | 86,310 | +58.9% | 3.90% | +114.0% |
| Q2 2013 | $3,036,000 | – | 54,310 | – | 1.82% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 545,583 | $34,715,000 | 10.89% |
| Murchinson Ltd. | 100,000 | $6,363,000 | 3.16% |
| Eversept Partners, LP | 179,366 | $11,413,059 | 0.79% |
| BRANDES INVESTMENT PARTNERS, LP | 266,560 | $16,962,000 | 0.37% |
| Analyst IMS Investment Management Services Ltd. | 22,755 | $1,447,000 | 0.18% |
| Claret Asset Management Corp | 9,336 | $594,000 | 0.10% |
| ACADIAN ASSET MANAGEMENT LLC | 344,023 | $21,851,000 | 0.08% |
| Renaissance Technologies | 720,500 | $45,845,000 | 0.06% |
| C M BIDWELL & ASSOCIATES LTD | 1,155 | $73,000 | 0.05% |
| First Trust Direct Indexing L.P. | 3,357 | $214,000 | 0.03% |